CEO Andrew Simpson discusses how we’re one of the only companies leading the use of an AI-enabled EKG medical device to make it a far more valuable screening tool.

CEO Andrew Simpson discusses how we’re one of the only companies leading the use of an AI-enabled EKG medical device to make it a far more valuable screening tool.

$HSCS CEO Andrew Simpson discusses how we’re one of the only companies leading the use of an AI-enabled EKG medical device to make it a far more valuable screening tool. #AI #cardiotwitter Thanks @PlanetMicroCap @BobbyKKraft

Full interview (7 min) → https://t.co/ESxOmnEbJ0 pic.twitter.com/rGLRCOZBV8

— HeartSciences $HSCS #AI #ECG (@HeartSciences) October 24, 2022